Abstract

Mice that express reduced levels of the c‐Myc gene (Myc +/− heterozygotes) are long‐lived. Myc hypomorphic mice display reduced rates of protein translation and decreased activity of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1). Given the prominent effect of mTOR on aging, lower mTORC1 activity could contribute to the exceptional longevity and enhanced healthspan of Myc +/− animals. However, given the downstream position of MYC in these signaling cascades, the mechanism through which mTORC1 activity is downregulated in Myc +/− mice is not understood. We report that the high‐affinity glutamine transporter SLC1A5, which is critical for activation of mTORC1 activity by amino acids, is a transcriptional target of MYC. Myc +/− cells display decreased Slc1a5 gene expression that leads to lower glutamine uptake and consequently reduced mTORC1 activity. Decreased mTORC1 activity in turn mediates an elevation of fatty acid oxidation (FAO) by indirectly upregulating the expression of carnitine palmitoyltransferase 1a (Cpt1a) that mediates the rate‐limiting step of β‐oxidation. Increased FAO has been noted in a number of long‐lived mouse models. Taken together, our results show that transcriptional feedback loops regulated by MYC modulate upstream signaling pathways such as mTOR and impact FAO on an organismal level.

Highlights

  • To further evaluate changes in fatty acid oxidation (FAO), we examined the expression carnitine palmitoyltransferase I genes that control the rate‐limiting steps of long‐chain fatty acid transport into mitochondria (McGarry & Brown, 1997; encoded by distinct carnitine palmitoyltransferase 1a (Cpt1a) and Cpt1b genes in liver and muscle, respectively)

  • Regulated glutamine uptake, GPNA. (e) Gene expression of Acadl in liver, (f) Acadl in muscle, (g) peroxisome proliferator‐activated receptor alpha (Ppara) in liver, (h) Srebf1 in liver, (i) Cpt1a in liver, and (j) Cpt1b in muscle. mRNA levels were determined by RT–qPCR under either ad libitum fed or overnight fasting conditions. (k)

  • Since we were able to inhibit mTORC1 activation by pharma‐ cologically interfering with SLC1A5‐mediated glutamine uptake (Figure 2a), and decreased mammalian target of rapamycin (mTOR) signaling in rapamycin‐treated cells induced FAO (Figure 2b,c), we asked whether inhibiting glutamine uptake was sufficient to induce FAO

Read more

Summary

SHORT TAKE

Xiaoai Zhao1 | Anna P. Petrashen1 | Jennifer A. Sanders2 | Abigail L. Peterson1 | John M. Sedivy1 Present address Xiaoai Zhao, Department of Genetics, Stanford University, Stanford, California Funding information National Institute on Aging, Grant/ Award Number: R37 AG016694 and T32 AG041688

Fed Fasted
Fatty Acid Oxidation
AUTHOR CONTRIBUTIONS
Findings
SUPPORTING INFORMATION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call